Artisan Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Artisan Partners’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-332,274	Closed	-$1.94M	–	341
2022 Q2	$1.94M	Sell	332,274 -201,603	-38%	-$1.14M	﹤0.01%	311
2022 Q1	$3.8M	Sell	533,877 -447,734	-46%	-$4.39M	0.01%	314
2021 Q4	$13M	Sell	981,611 -103,031	-9%	-$1.7M	0.02%	314
2021 Q3	$24.9M	Sell	1,084,642 -259,661	-19%	-$7.72M	0.03%	284
2021 Q2	$59M	Buy	1,344,303 +279,924	+26%	+$15.6M	0.07%	228
2021 Q1	$77.3M	Buy	1,064,379 +661,798	+164%	+$47M	0.1%	213
2020 Q4	$17.4M	Buy	402,581 +37,425	+10%	+$1.68M	0.02%	301
2020 Q3	$15M	Buy	365,156 +80,769	+28%	+$4.17M	0.02%	294
2020 Q2	$17.1M	Buy	284,387 +34,851	+14%	+$3.19M	0.03%	275
2020 Q1	$18.8M	Sell	249,536 -19,497	-7%	-$2.25M	0.04%	238
2019 Q4	$37M	Buy	269,033 +94,444	+54%	+$11.5M	0.06%	213
2019 Q3	$20.7M	Buy	174,589 +8,245	+5%	+$1.15M	0.04%	233
2019 Q2	$23.3M	Buy	+166,344	New	+$29.2M	0.04%	229

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Artisan Partners's ORTX Position: Q3 2022 in Review

Artisan Partners sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2022, closing a stake of 332,274 shares — an estimated $1.94M sold.

Artisan Partners first reported a position in ORTX in Q2 2019 and held it in 13 quarters. The position peaked at $77.3M in Q1 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

Artisan Partners reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Artisan Partners sold 332,274 Orchard Therapeutics plc American Depositary Shares shares in Q3 2022, an estimated $1.94M.
Artisan Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 13 quarters.
Artisan Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $77.3M in Q1 2021.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on Artisan Partners's 13F filing for Q3 2022, filed 10 Nov 2022.